arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Nuwellis, Inc.

NUWE
$0.84 0.00 (+0.54%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
63 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

Nuwellis, Inc. faces fundamental challenges with weakness in Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth 14.1%
Op. Margin -160.9%
ROIC 154.2%
FCF / Share $-17.57
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

63-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.97M
↑ +14.1%
Net Income Profit after all expenses
$-4.54M
↓ -50.7%
Operating Margin Operating profit as % of sales
-160.9%
↑ +15.3% 1th
FCF / Share Free cash flow per share
$-17.57
↓ -1060.1%
Long-Term Debt Long-term obligations
$1.97M
↓ -33.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
1
Cash Quality
45

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 16 years · 63 quarters